On November 5, Fang Tonghua, Chairman of Zhenbaodao Group, led relevant executives and experts from the group on a visit to DiQi Pharmaceuticals Co., Ltd. They engaged in in-depth discussions on projects and technologies with DiQi Pharmaceuticals Co., Ltd.'s senior management team and project leaders. Zhang Ling, Executive Vice President of DiQi Pharmaceuticals Co., Ltd., and Dr. Peng Tangsheng, Vice President, respectively introduced the company's overview and quality system, and guided the delegation on a tour of the laboratory and office areas.

Chairman Fang Tonghua of Zhenbaodao Group expressed recognition of the technical and innovative capabilities of the DiQi Pharmaceuticals Co., Ltd team. He hopes that during the R&D process, projects selected for development will closely integrate with medical insurance and clinical applications, thereby securing a competitive edge in future market sales.

Both parties hope to join forces as strong partners, seeking entry points and leverage for cooperation to achieve mutual benefit and win-win outcomes, and pursue shared development.